COUNTERVAILING POWER IN WHOLESALE PHARMACEUTICALSSARA FISHER ELLISON; CHRISTOPHER M. SNYDER · 2010

The cellular pharmacology of auranofinRosanne M. Snyder; Christopher K. Mirabelli; Stanley T. Crooke · 1987

Preventives Versus TreatmentsKremer, Michael; Snyder, Christopher M. · The Quarterly Journal of Economics · 2015

Pediatric reconstructive surgeryCooper, Christopher S.; Snyder, Howard M. · Current Opinion in Urology · 2000

Vertical Foreclosure in Experimental MarketsMartin, Stephen NMI; Normann, Hans Theo; Snyder, Christopher M. · SSRN Electronic Journal · 2000

Resume Padding Among EconomistsSnyder, Christopher M.; Zidar, Owen M. · SSRN Electronic Journal · 2011

Vertical Foreclosure in Experimental MarketsStephen Martin, Hans-Theo Normann and Christopher M. Snyder · The RAND Journal of Economics · 2001

Reputational Cheap TalkMarco Ottaviani and Peter Norman Sørensen · The RAND Journal of Economics · 2006

Regulation, Asymmetric Information, and AuditingDavid P. Baron and David Besanko · The RAND Journal of Economics · 1984

Cheap Talk, Coordination, and EntryJoseph Farrell · The RAND Journal of Economics · 1987

Standardization, Compatibility, and InnovationJoseph Farrell and Garth Saloner · The RAND Journal of Economics · 1985

Colluding through suppliersPiccolo, Salvatore; Miklós-Thal, Jeanine · The RAND Journal of Economics · 2012

The economics of network neutralityEconomides, Nicholas; Hermalin, Benjamin E. · The RAND Journal of Economics · 2012

Endogenous market segmentation for lemonsKim, Kyungmin · The RAND Journal of Economics · 2012

Firm Behavior in Franchise Monopoly MarketsRobin A. Prager · The RAND Journal of Economics · 1990